Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,031 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.
Othman J, Tiong IS, O'Nions J, Dennis M, Mokretar K, Ivey A, Austin M, Latif AL, Amer M, Chan WY, Crawley C, Crolla F, Cross J, Dang R, Elliot J, Fong CY, Galli S, Gallipoli P, Hogan F, Kalkur P, Khan A, Krishnamurthy P, Laurie J, Loo S, Marshall S, Mehta P, Murthy V, Nagumantry S, Pillai S, Potter N, Sellar R, Taylor T, Zhao R, Russell NH, Wei AH, Dillon R. Othman J, et al. Among authors: taylor t. Blood. 2024 Jan 25;143(4):336-341. doi: 10.1182/blood.2023021579. Blood. 2024. PMID: 37647641
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.
Othman J, Hwang A, Brodermann M, Abdallah I, McCloskey K, Gallipoli P, Clarke G, Dang R, Vidler J, Krishnamurthy P, Basheer F, Latif AL, Palanicawandar R, Taylor T, Khan A, Campbell V, Hogan F, Kanellopoulos A, Fleming K, Collins A, Dalley C, Loke J, Marshall S, Taussig D, Munisamy S, Loizou E, Yassin H, Dennis M, Zhao R, Belsham E, Murray D, Fowler N, O'Nions J, Khan A, Sellar R, Dillon R. Othman J, et al. Among authors: taylor t. Blood Adv. 2024 Nov 12;8(21):5590-5597. doi: 10.1182/bloodadvances.2024014017. Blood Adv. 2024. PMID: 39265176 Free PMC article.
Dr. Roberts et al reply.
Roberts JH, Gunn C, Mackinnon JE, Parlee S, Bakowsky V, Taylor T, Barber CEH, Hanly JG, Legge A. Roberts JH, et al. Among authors: taylor t. J Rheumatol. 2024 Dec 15:jrheum.2024-1091. doi: 10.3899/jrheum.2024-1091. Online ahead of print. J Rheumatol. 2024. PMID: 39681379 No abstract available.
Improvements in large-scale production of Tobacco Etch Virus protease.
Messing S, Barnhart K, Drew M, Granato-Guerrero N, Grose C, Higgins B, Hong M, Hull J, Perkins S, Poon I, Ramakrishnan N, Seabolt A, Taylor T, Wall VE, Wright N, Gillette W, Esposito D. Messing S, et al. Among authors: taylor t. Protein Expr Purif. 2024 Dec 14:106648. doi: 10.1016/j.pep.2024.106648. Online ahead of print. Protein Expr Purif. 2024. PMID: 39681152
Transcription processes compete with loop extrusion to homogenize promoter and enhancer dynamics.
Platania A, Erb C, Barbieri M, Molcrette B, Grandgirard E, de Kort MAC, Pomp W, Meaburn K, Taylor T, Shchuka VM, Kocanova S, Nazarova M, Oliveira GM, Mitchell JA, Soutoglou E, Lenstra TL, Molina N, Papantonis A, Bystricky K, Sexton T. Platania A, et al. Among authors: taylor t. Sci Adv. 2024 Dec 13;10(50):eadq0987. doi: 10.1126/sciadv.adq0987. Epub 2024 Dec 13. Sci Adv. 2024. PMID: 39671497 Free PMC article.
3,031 results